
Entertainment
By TrendScope Daily Team · October 30, 2026
Nobody in Hollywood expected a nearly three-hour documentary about a convicted fraudster to out-earn a Street Fighter movie. But that is precisely what happened this month, as “You Can See Everything,” Nathan Fielder and Lance Oppenheim’s A24 documentary about Theranos founder Elizabeth Holmes, has turned into one of the strangest and most durable box office stories of 2026. Two weekends after opening to a stunned $15 million debut, the film actually grew, pulling in $19.5 million as it expanded nationwide — a trajectory almost no theatrical release, fiction or nonfiction, manages anymore.
A documentary built on secrecy
A24 produced “You Can See Everything” in secret over roughly three years, on a budget of about $7 million, after Holmes herself reportedly reached out about having someone document her life in the weeks before she reported to federal prison. The studio gave Fielder and Oppenheim a modest budget and the freedom to walk away if nothing worth telling emerged on camera. Something did: the filmmakers ended up following Holmes and her partner, Billy Evans, for 34 days beginning before her sentencing, then kept returning over roughly three years, long enough to capture her eventual push for early release.
The film premiered as a surprise addition to the Telluride Film Festival lineup in September, catching even festival regulars off guard, before A24 opened it wide — a risky move for a documentary of its length and subject matter — on 855 screens on October 16.
Numbers nobody saw coming
Pre-weekend tracking had pegged the opening at $7 million to $8 million. Instead, “You Can See Everything” debuted to $15 million, finishing second for the weekend behind Paramount’s “Street Fighter” ($31 million) but posting the largest opening ever for a film on fewer than 1,000 screens since Sacha Baron Cohen’s “Borat” in 2006, and the biggest documentary debut in more than two decades, trailing only “Fahrenheit 9/11,” which opened to $23.9 million in 2004.
Then came the real surprise. Rather than falling off in its second weekend, as almost every wide release does, the film climbed 25% to $19.5 million as A24 widened it from 855 theaters to 2,655, pushing its domestic total to $45.1 million and landing it second again, this time behind the new horror opener “Clayface.” Box office analyst David A. Gross called it “a giant weekend for the genre,” while Rentrak’s Paul Dergarabedian noted that the result fit a pattern: “This is yet another eclectic, interesting weekend, and that has been the hallmark of 2026.”
A24 says the film has notched more than 2,000 sold-out screenings. Exit polling found about 70% of opening-weekend audiences were under 35, with 90% saying they would “definitely recommend” the film and 80% calling it “even better than expected.” Critics have largely agreed: the film holds a 98% approval rating on Rotten Tomatoes, among the best-reviewed wide releases of the year.
Fielder’s unusual way in
What distinguishes “You Can See Everything” from a conventional true-crime documentary is its refusal to simply re-litigate the Theranos fraud that sent Holmes to prison for eleven years. Fielder and Oppenheim instead sit with the discomfort of being granted access to Holmes at her most unguarded, and let their own disagreements about what they were witnessing become part of the film. Speaking afterward, Fielder described the strange intimacy of the shoot.
“When I met her, I remember having this weird experience where she seems so genuine at times. But then I’m like, ‘no,’ and clocking and tracking my thoughts.”
— Nathan Fielder, co-director, to The Daily Beast
Fielder has said he and Oppenheim frequently disagreed about what they were seeing in real time — “we’d completely disagree on what something meant to us and what we thought was happening” — and that the finished film leans into that friction rather than resolving it. He has also acknowledged he isn’t sure why Holmes trusted the project at all, saying only that she described it to him as wanting to tell “a human story.”
Holmes’s shadow still looms
The film’s box office run has unfolded alongside real developments in Holmes’s own case. She is currently serving an 11-year sentence for defrauding Theranos investors and maintains her innocence. She requested early release in a petition to President Trump in December 2025, and the Federal Bureau of Prisons approved a transfer on September 24, with Holmes set to move to a residential halfway house in Texas next year. Her public reaction to that news — sharing a post from Trump with the caption “We are winning” — has only added to the attention surrounding the documentary’s release, with outlets reporting that Evans pushed back on aspects of how the film portrayed their relationship during production.
For readers who want the fuller paper trail behind Theranos’s collapse before diving into Fielder’s more impressionistic take, John Carreyrou’s reporting remains the definitive account. His book Bad Blood is widely considered the record of how Theranos’s fraud actually unraveled, and makes a natural companion to the documentary’s more intimate, unresolved portrait of Holmes herself.
As an Amazon Associate, TrendScope Daily earns from qualifying purchases made through links in this article.
Quick questions
What is You Can See Everything?
An A24 documentary by Nathan Fielder and Lance Oppenheim about Theranos founder Elizabeth Holmes.
How much has You Can See Everything earned?
It opened to $15 million, grew to $19.5 million in its second weekend and passed $45 million domestically.
What was the budget of You Can See Everything?
About $7 million, filmed in secret over roughly three years.
Related on TrendScope Daily
- Hollywood’s Sequel Machine Hit a New Gear in 2026 — Here’s Why Nostalgia Is Doing So Much Heavy Lifting
- BTS’s São Paulo Arirang Shows Just Cracked the North American Box Office Top 10
- A Six-Screen Indie About a New York Pickpocket Just Cracked the Box Office Top 10
- More Entertainment stories: browse the Entertainment section
Bottom line
Documentaries almost never behave like this at the box office — they open small, play to converts, and fade. “You Can See Everything” has instead grown in its second weekend, crossed $45 million domestically, and drawn some of the best reviews of any film released in 2026, all while its real-life subject’s legal situation continues to evolve in public view. As A24 keeps expanding the release into November, the film looks less like a curiosity and more like a genuine marker of how audiences are willing to show up for nonfiction storytelling when the story itself refuses easy answers.